Inoviv Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
2ndary - Private
- Investors
-
13
Inoviv General Information
Description
Developer of a proteomics platform intended to provide molecular insights into drug response. The company's platform uses an accurate, fully quantitative, and targeted biomarker analysis to accelerate clinical trials in multiple disease areas, enabling pharmaceutical companies to run successful clinical trials and maximize access to marketed therapies.
Contact Information
Website
www.inoviv.comCorporate Office
- Fox Court 14 Grays Inn Road
- 136 High Holborn
- London WC1X 8HN
- England, United Kingdom
Corporate Office
- Fox Court 14 Grays Inn Road
- 136 High Holborn
- London WC1X 8HN
- England, United Kingdom
Inoviv Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 6. Later Stage VC | 30-Jan-2024 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 28-Jan-2022 | Completed | Generating Revenue | |||
| 4. Grant | 01-Aug-2020 | Completed | Generating Revenue | |||
| 3. Grant | 01-May-2020 | Completed | Generating Revenue | |||
| 2. Seed Round | 01-Jan-2021 | $1.03M | $1.04M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 23-Mar-2018 | $13.9K | $13.9K | Completed | Generating Revenue |
Inoviv Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series Seed -2 | ||||||||
| Series Seed -2 | ||||||||
| Ordinary | ||||||||
| Series Seed -2 | ||||||||
| Ordinary | ||||||||
| Series Seed | ||||||||
| Series Seed | ||||||||
| Series Seed | 6,173 | $0.001271 | $54.54 | $54.54 | 1x | $54.54 | 3.82% | |
| Ordinary | 8,000 | $0.001271 | $1.59 | $1.59 | 1x | $1.59 | 4.95% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Inoviv Comparisons
Industry
Financing
Details
Inoviv Competitors (2)
One of Inoviv’s 2 competitors is Olink Proteomics, a Formerly PE-Backed company based in Uppsala, Sweden.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Olink Proteomics | Formerly PE-Backed | Uppsala, Sweden | ||||
| SomaLogic Operating Company | Formerly PE-Backed | Boulder, CO |
Inoviv Patents
Inoviv Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202417740-D0 | Muscular dystrophy assay | Inactive | 03-Dec-2024 | ||
| GB-202415575-D0 | Neurodegenrative disease biomarker assay | Inactive | 22-Oct-2024 | ||
| GB-202408899-D0 | Method for diagnosing and/or classifying the severity of a neurodegenerative disease | Inactive | 20-Jun-2024 | ||
| GB-202318092-D0 | Muscular dystrophy assay | Inactive | 27-Nov-2023 | ||
| GB-202316201-D0 | Method for diagnosing and/or classifying the severity of a neurodegenerative disease | Inactive | 23-Oct-2023 |
Inoviv Signals
Inoviv Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Foresight Group | Asset Manager | Minority | ||
| Foresight Ventures VCT | Venture Capital | Minority | ||
| Kinled Holding | Family Office | Minority | ||
| Verve Ventures | Venture Capital | Minority | ||
| Beast Ventures | Venture Capital | Minority |
Inoviv FAQs
-
When was Inoviv founded?
Inoviv was founded in 2018.
-
Where is Inoviv headquartered?
Inoviv is headquartered in London, United Kingdom.
-
What is the size of Inoviv?
Inoviv has 21 total employees.
-
What industry is Inoviv in?
Inoviv’s primary industry is Drug Delivery.
-
Is Inoviv a private or public company?
Inoviv is a Private company.
-
What is Inoviv’s current revenue?
The current revenue for Inoviv is .
-
How much funding has Inoviv raised over time?
Inoviv has raised $8.43M.
-
Who are Inoviv’s investors?
Foresight Group, Foresight Ventures VCT, Kinled Holding, Verve Ventures, and Beast Ventures are 5 of 13 investors who have invested in Inoviv.
-
Who are Inoviv’s competitors?
Olink Proteomics and SomaLogic Operating Company are competitors of Inoviv.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process